Reappointment of Mr. Swaminathan (DIN: 02481041) as Whole-time director for a period of five years
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech's board, at its meeting on 30-08-2025, approved multiple items including the 33rd AGM on 29-09-2025 and the Director's Report for FY25. Mr. Swaminathan (DIN: 02481041) was reappointed as Whole-time Director for five years, along with similar appointments for Mr. Singarababu Indirakumar and Mr. Muthukrishnan Ramesh, and a new Independent Director, Dr. Bokara Nagarajan Padmaja Priyadarshini. The board also approved disinvestment from material subsidiary Dindigul Farm Product Limited (DFPL), which contributed 47.11% to consolidated turnover (Rs. 6,282.81 lakhs) and 35.24% to consolidated net worth (Rs. 3,521.13 lakhs) in FY25, with DFPL's status also being reclassified from 'Promoter' to 'Public'. Authorised share capital was raised to Rs. 85 crore, and material related party transactions up to Rs. 25 crore were approved with six subsidiaries.
The disinvestment from DFPL is significant for shareholders since the subsidiary contributed nearly half of consolidated revenue and over a third of net worth; how the sale is priced and executed will be closely watched. The board restructuring and authorised capital increase suggest the company is preparing for future fundraising or expansion plans.